Index RUT
P/E -
EPS (ttm) -0.49
Insider Own 5.58%
Shs Outstand 43.12M
Perf Week 1.32%
Market Cap 403.79M
Forward P/E 103.44
EPS next Y 0.09
Insider Trans -4.62%
Shs Float 41.26M
Perf Month 23.20%
Income -21.28M
PEG -
EPS next Q -0.07
Inst Own 80.39%
Short Float 5.91%
Perf Quarter 41.72%
Sales 163.73M
P/S 2.47
EPS this Y -9.16%
Inst Trans 4.16%
Short Ratio 7.31
Perf Half Y -2.84%
Book/sh 2.13
P/B 4.33
EPS next Y 148.14%
ROA -11.32%
Short Interest 2.44M
Perf Year 5.24%
Cash/sh 0.54
P/C 17.09
EPS next 5Y -
ROE -22.32%
52W Range 3.45 - 10.83
Perf YTD 35.29%
Dividend Est. -
P/FCF -
EPS past 5Y 3.44%
ROI -13.24%
52W High -14.70%
Beta 1.06
Dividend TTM -
Quick Ratio 2.23
Sales past 5Y 13.87%
Gross Margin 79.73%
52W Low 167.83%
ATR (14) 0.47
Dividend Ex-Date Jan 27, 2010
Current Ratio 3.43
EPS Y/Y TTM 14.89%
Oper. Margin -11.41%
RSI (14) 66.02
Volatility 5.51% 5.78%
Employees 428
Debt/Eq 0.74
Sales Y/Y TTM 13.51%
Profit Margin -13.00%
Recom 1.14
Target Price 12.71
Option/Short Yes / Yes
LT Debt/Eq 0.72
EPS Q/Q 7.64%
Payout -
Rel Volume 0.53
Prev Close 9.33
Sales Surprise -1.38%
EPS Surprise 11.76%
Sales Q/Q 12.86%
Earnings Aug 08 BMO
Avg Volume 333.70K
Price 9.24
SMA20 10.55%
SMA50 24.22%
SMA200 26.93%
Trades
Volume 178,133
Change -0.96%
Date
Action
Analyst
Rating Change
Price Target Change
Jul-01-24 Initiated
Raymond James
Outperform
$13
Nov-11-22 Resumed
Jefferies
Buy
$15
May-09-22 Upgrade
Canaccord Genuity
Hold → Buy
$10 → $15
Mar-11-22 Resumed
Cantor Fitzgerald
Overweight
$21
Oct-23-20 Initiated
Guggenheim
Buy
$24
Jun-16-20 Resumed
Cantor Fitzgerald
Overweight
$16
May-07-20 Downgrade
Canaccord Genuity
Buy → Hold
$12
Apr-02-20 Downgrade
BTIG Research
Buy → Neutral
Aug-07-19 Downgrade
William Blair
Outperform → Mkt Perform
Jul-12-19 Initiated
Canaccord Genuity
Buy
$32
Mar-02-18 Reiterated
Lake Street
Buy
$26 → $38
Jan-05-18 Resumed
Cantor Fitzgerald
Overweight
Nov-30-17 Initiated
Jefferies
Buy
$35
Nov-21-17 Reiterated
Lake Street
Buy
$22 → $26
Jul-31-17 Initiated
Leerink Partners
Outperform
$22
Jun-30-17 Initiated
Cantor Fitzgerald
Overweight
$18
Mar-06-17 Initiated
ROTH Capital
Buy
$14.50
Nov-22-16 Upgrade
Lake Street
Hold → Buy
$9 → $11
Nov-07-16 Reiterated
Wedbush
Outperform
$10 → $12
Nov-03-16 Downgrade
Lake Street
Buy → Hold
$9
Show Previous Ratings
Jul-23-24 07:00AM
Jul-12-24 08:37AM
Jul-01-24 07:00AM
Jun-25-24 12:52PM
Jun-24-24 07:00AM
04:56AM
Loading…
Jun-12-24 04:56AM
May-28-24 04:30PM
May-17-24 12:29PM
May-16-24 02:56PM
07:00AM
May-14-24 07:00AM
May-06-24 10:31AM
May-03-24 03:02AM
May-02-24 11:57AM
08:15AM
07:14AM
Loading…
07:14AM
(Associated Press Finance)
07:00AM
Apr-29-24 04:50PM
Apr-16-24 07:00AM
Mar-08-24 11:55PM
Mar-06-24 08:20AM
Mar-05-24 09:27PM
(Thomson Reuters StreetEvents) -15.11%
11:53AM
07:38AM
(Associated Press Finance)
07:31AM
07:00AM
Feb-28-24 08:50AM
Feb-26-24 09:15AM
Feb-13-24 04:30PM
Feb-12-24 08:50AM
09:40AM
Loading…
Feb-06-24 09:40AM
Feb-02-24 04:15PM
Jan-26-24 08:50AM
Jan-18-24 05:00PM
Jan-04-24 04:45PM
04:40PM
04:35PM
Dec-26-23 04:15PM
Dec-06-23 07:00AM
Dec-01-23 05:00PM
Nov-20-23 07:00AM
Nov-08-23 09:41AM
Nov-07-23 11:01PM
(Thomson Reuters StreetEvents) +36.90%
08:04AM
07:15AM
(Associated Press Finance)
07:00AM
Nov-02-23 10:00AM
Oct-31-23 10:01AM
Oct-18-23 07:00AM
Oct-16-23 10:23AM
Sep-28-23 08:21AM
Sep-05-23 07:00AM
Aug-31-23 07:00AM
Aug-21-23 07:00AM
Aug-10-23 03:03PM
12:05PM
Aug-08-23 10:59AM
(Simply Wall St.) -19.44%
05:57AM
(Thomson Reuters StreetEvents)
Aug-07-23 05:25PM
04:18PM
04:01PM
Aug-03-23 05:55PM
Jul-27-23 07:00AM
Jul-26-23 07:00AM
Jun-10-23 10:42AM
Jun-09-23 09:55AM
May-24-23 07:00AM
May-12-23 07:00AM
May-09-23 08:35AM
07:34AM
07:00AM
Apr-18-23 04:05PM
07:25AM
Mar-17-23 04:31AM
Mar-16-23 06:30AM
Mar-14-23 11:23PM
(Thomson Reuters StreetEvents) +11.95%
07:00AM
Mar-06-23 07:00AM
Mar-02-23 04:00PM
Mar-01-23 09:21AM
Feb-13-23 07:00AM
Jan-09-23 07:00AM
Jan-05-23 07:00AM
Jan-04-23 07:00AM
Jan-01-23 08:52AM
Dec-19-22 07:00AM
Nov-11-22 08:50AM
Nov-08-22 08:15AM
08:00AM
(Thomson Reuters StreetEvents)
07:00AM
Nov-03-22 04:00PM
Oct-31-22 07:00AM
Oct-27-22 12:00PM
Oct-20-22 07:00AM
Oct-19-22 09:40AM
Sep-29-22 05:32AM
Sep-22-22 09:55AM
07:00AM
Aug-08-22 09:55AM
09:40AM
Axogen, Inc. engages in the development and market of surgical solutions for peripheral nerve regeneration and repair. It also provides products and education to improve surgical treatment algorithms for peripheral nerve damage or discontinuity. The firm's products include avance nerve graft, axoguard nerve connector, axoguard nerve protector, avive soft tissue membrane, acroval neurosensory and motor testing system, and axotouch two-point discriminator. The company was founded in 1977 and is headquartered in Alachua, FL.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Freitag Gregory Gene Director Jun 04 '24 Option Exercise 0.00 11,904 0 283,498 Jun 06 04:49 PM Scopelianos Angelo Chief R&D Officer Mar 21 '24 Option Exercise 0.00 2,500 0 58,604 Mar 25 09:37 PM Zaderej Karen L. CEO Mar 21 '24 Sale 7.68 39,280 301,670 1,124,565 Mar 25 09:43 PM Scopelianos Angelo Chief R&D Officer Mar 21 '24 Sale 7.68 6,881 52,846 52,999 Mar 25 09:37 PM Donovan Michael Patrick VP Operations Mar 21 '24 Sale 7.68 6,033 46,333 37,992 Mar 25 09:22 PM DeVinney Erick Wayne Chief Innovation Officer Mar 21 '24 Sale 7.68 4,578 35,159 165,661 Mar 25 09:40 PM Zaderej Karen L. CEO Mar 16 '24 Option Exercise 0.00 110,322 0 1,157,593 Mar 25 09:43 PM DeVinney Erick Wayne Chief Innovation Officer Mar 16 '24 Option Exercise 0.00 18,675 0 180,615 Mar 25 09:40 PM Scopelianos Angelo Chief R&D Officer Mar 16 '24 Option Exercise 0.00 25,406 0 58,250 Mar 25 09:37 PM Donovan Michael Patrick VP Operations Mar 16 '24 Option Exercise 0.00 24,575 0 58,846 Mar 25 09:22 PM Donovan Michael Patrick VP Operations Mar 07 '24 Sale 8.81 36,310 319,891 35,708 Mar 08 05:33 PM Freitag Gregory Gene Director Mar 07 '24 Sale 9.00 25,000 225,000 271,594 Mar 08 05:31 PM MARIANI PETER J EVP & Chief Financial Officer Dec 11 '23 Sale 7.50 12,500 93,809 63,603 Dec 13 04:07 PM Wendell Amy McBride Director Sep 06 '23 Buy 6.22 10,000 62,240 80,342 Sep 08 04:20 PM Burke William P. Mr. Director Aug 23 '23 Buy 6.56 10,000 65,600 10,000 Aug 25 04:16 PM NEELS GUIDO J Director Aug 16 '23 Buy 6.11 10,000 61,100 68,259 Aug 18 04:12 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite